The combination of CRP and troponin has been sporadically evaluated jointly to evaluate the risk of cardiac disease and death in stable end-stage renal failure patients on dialysis [11] or to assess prognosis in acute coronary patients [12]. The gene discussed is CRP; the disease is heart disorder.